First Time Loading...
N

Nichi-Iko Pharmaceutical Co Ltd
TSE:4541

Watchlist Manager
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Watchlist
Price: 0.0001 JPY Market Closed
Updated: Apr 16, 2024

Intrinsic Value

Nichi-Iko Pharmaceutical Co., Ltd. engages in the manufacturing, sales, distribution, export, import and related activities for various types of pharmaceutical products. [ Read More ]

There is not enough data to reliably calculate the intrinsic value of Nichi-Iko Pharmaceutical Co Ltd.

Key Points:
Intrinsic Value
Base Case
Not Available
N
Base Case Scenario

Fundamental Analysis

Beta
Ask me anything about
Nichi-Iko Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Nichi-Iko Pharmaceutical Co Ltd.

What unique competitive advantages
does Nichi-Iko Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Nichi-Iko Pharmaceutical Co Ltd face in the near future?

Show all valuation multiples
for Nichi-Iko Pharmaceutical Co Ltd.

Provide P/S
for Nichi-Iko Pharmaceutical Co Ltd.

Provide P/E
for Nichi-Iko Pharmaceutical Co Ltd.

Provide P/OCF
for Nichi-Iko Pharmaceutical Co Ltd.

Provide P/FCFE
for Nichi-Iko Pharmaceutical Co Ltd.

Provide P/B
for Nichi-Iko Pharmaceutical Co Ltd.

Provide EV/S
for Nichi-Iko Pharmaceutical Co Ltd.

Provide EV/GP
for Nichi-Iko Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Nichi-Iko Pharmaceutical Co Ltd.

Provide EV/EBIT
for Nichi-Iko Pharmaceutical Co Ltd.

Provide EV/OCF
for Nichi-Iko Pharmaceutical Co Ltd.

Provide EV/FCFF
for Nichi-Iko Pharmaceutical Co Ltd.

Provide EV/IC
for Nichi-Iko Pharmaceutical Co Ltd.

Show me price targets
for Nichi-Iko Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Nichi-Iko Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Nichi-Iko Pharmaceutical Co Ltd?

What are the Net Income projections
for Nichi-Iko Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Nichi-Iko Pharmaceutical Co Ltd?

What are the EPS projections
for Nichi-Iko Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Nichi-Iko Pharmaceutical Co Ltd?

What are the EBIT projections
for Nichi-Iko Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Nichi-Iko Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Nichi-Iko Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nichi-Iko Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nichi-Iko Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nichi-Iko Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Nichi-Iko Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Nichi-Iko Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Nichi-Iko Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Nichi-Iko Pharmaceutical Co Ltd.

Provide ROE
for Nichi-Iko Pharmaceutical Co Ltd.

Provide ROA
for Nichi-Iko Pharmaceutical Co Ltd.

Provide ROIC
for Nichi-Iko Pharmaceutical Co Ltd.

Provide ROCE
for Nichi-Iko Pharmaceutical Co Ltd.

Provide Gross Margin
for Nichi-Iko Pharmaceutical Co Ltd.

Provide Operating Margin
for Nichi-Iko Pharmaceutical Co Ltd.

Provide Net Margin
for Nichi-Iko Pharmaceutical Co Ltd.

Provide FCF Margin
for Nichi-Iko Pharmaceutical Co Ltd.

Show all solvency ratios
for Nichi-Iko Pharmaceutical Co Ltd.

Provide D/E Ratio
for Nichi-Iko Pharmaceutical Co Ltd.

Provide D/A Ratio
for Nichi-Iko Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Nichi-Iko Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Nichi-Iko Pharmaceutical Co Ltd.

Provide Quick Ratio
for Nichi-Iko Pharmaceutical Co Ltd.

Provide Current Ratio
for Nichi-Iko Pharmaceutical Co Ltd.

Provide Cash Ratio
for Nichi-Iko Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Nichi-Iko Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Nichi-Iko Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Nichi-Iko Pharmaceutical Co Ltd?

AI Assistant can make mistakes. Consider checking important information.
Financials

Balance Sheet Decomposition
Nichi-Iko Pharmaceutical Co Ltd

Current Assets 177.1B
Cash & Short-Term Investments 13.3B
Receivables 70.3B
Other Current Assets 93.4B
Non-Current Assets 69.4B
Long-Term Investments 11.1B
PP&E 35.9B
Intangibles 22.2B
Other Non-Current Assets 238m
Current Liabilities 182.6B
Accounts Payable 40.7B
Other Current Liabilities 141.9B
Non-Current Liabilities 99.7B
Long-Term Debt 71.8B
Other Non-Current Liabilities 27.9B
Efficiency

Earnings Waterfall
Nichi-Iko Pharmaceutical Co Ltd

Revenue
184.4B JPY
Cost of Revenue
-189.1B JPY
Gross Profit
-4.7B JPY
Operating Expenses
-149.2B JPY
Operating Income
-153.9B JPY
Other Expenses
8.7B JPY
Net Income
-145.2B JPY

Free Cash Flow Analysis
Nichi-Iko Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Nichi-Iko Pharmaceutical Co Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Positive Revenue Growth Forecast
Negative Gross Profit
Negative 1-Year Revenue Growth
Declining ROE
18/100
Profitability
Score

Nichi-Iko Pharmaceutical Co Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Nichi-Iko Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
50/100
Solvency
Score

Nichi-Iko Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Nichi-Iko Pharmaceutical Co Ltd

There are no price targets for Nichi-Iko Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Nichi-Iko Pharmaceutical Co Ltd

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-
5Y 5Y
-
10Y 10Y
+1%
Annual Price Range
0.0001
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown
N/A
Shares Statistics
Market Capitalization 776 550.9T JPY
Shares Outstanding 246 363 919 070 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Nichi-Iko Pharmaceutical Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

776 550.9T JPY

Dividend Yield

0%

Description

Nichi-Iko Pharmaceutical Co., Ltd. engages in the manufacturing, sales, distribution, export, import and related activities for various types of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 2,725 full-time employees. The firm provides its products to medical institutions such as hospitals, medical clinics and dispensing pharmacies. Its medical products are divided into prescription medicine products which are formulated according to a prescription issued by a doctor in a hospitals or clinics, as well as over-the-counter pharmaceutical products which can be purchased at pharmacies and drugstores without a prescription needed.

Contact

TOYAMA-KEN
Toyama-shi
1-6-21, Sogawa
+81764322121.0
https://www.nichiiko.co.jp/

IPO

1980-07-01

Employees

2 725

Officers

Pres, CEO, Representative Director & Compliance Supervisor
Mr. Yuiichi Tamura
EVP, GM of Admin. Division, Managing Exec. Officer & Director
Mr. Shuji Ishida
Sr. Exec. Officer & Head of Quality Assurance & Pharmacovigilance Division
Hiroshi Shimazaki
Sr. Exec. Officer & Head of Corp. Strategy & Planning Division
Mr. Takashi Kashiwagi
Managing Exec. Officer, GM of the Pres's Office & Director
Mr. Susumu Kanda
EVP, Managing Exec. Officer, GM of the Quality Control Division & Director
Mr. Hirotoshi Naruse
Show More
Sr. Exec. Officer
Keiji Nagae
Show Less

See Also

Discover More